Global Opioid Use Disorder (OUD) Market 2020 Industry Outlook

0
0

 The global opioid use disorder (OUD) market size is projected to reach USD 4.50 billion by 2026, exhibiting a CAGR of 10.8% during the forecast period. Increasing addiction to opioids across the globe will be the central force driving the growth of this market, shares Fortune Business Insights™ in its recent report, titled “Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026”.

Please visit: https://www.fortunebusinessinsights.com/opioid-use-disorder-oud-market-102674

Detailed Table of Content:

 

  1. Introduction

1.1.    Research Scope

1.2.    Market Segmentation

1.3.    Research Methodology

1.4.    Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.    Market Drivers

3.2.    Market Restraints

3.3.    Market Opportunities

  1. Key Insights

4.1.    Pipeline Analysis

4.2.    New Product Launches

4.3.    Statistics of Opioid Use Disorder

4.4.    Industry Developments Such as Mergers, Acquisitions, and Collaborations

  1. Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

5.1.    Key Findings / Summary

5.2.    Market Analysis, Insights and Forecast – By Drug Class

5.2.1. Buprenorphine

5.2.2. Methadone

5.2.3. Naltrexone

5.3.    Market Analysis, Insights and Forecast – By Route of Administration

5.3.1. Oral

5.3.2. Parenteral

5.4.    Market Analysis, Insights and Forecast – By Distribution Channel

5.4.1. Hospitals Pharmacies

5.4.2. Retail Pharmacies & Stores

5.4.3. Online Pharmacies

5.5.    Market Analysis, Insights and Forecast – By Region

5.5.1. North America

5.5.2. Europe

5.5.3. Asia Pacific

5.5.4. Rest of the World

  1. North America Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

6.1.    Key Findings / Summary

6.2.    Market Analysis – By Drug Class

6.2.1. Buprenorphine

6.2.2. Methadone

6.2.3. Naltrexone

6.3.    Market Analysis – By Route of Administration

6.3.1. Oral

6.3.2. Parenteral

6.4.    Market Analysis – By Distribution Channel

6.4.1. Hospitals Pharmacies

6.4.2. Retail Pharmacies & Stores

6.4.3. Online Pharmacies

6.5.    Market Analysis – By Country

6.5.1. U.S.

6.5.2. Canada

  1. Europe Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

7.1.    Key Findings / Summary

7.2.    Market Analysis – By Drug Class

7.2.1. Buprenorphine

7.2.2. Methadone

7.2.3. Naltrexone

7.3.    Market Analysis – By Route of Administration

7.3.1. Oral

7.3.2. Parenteral

7.4.    Market Analysis – By Distribution Channel

7.4.1. Hospitals Pharmacies

7.4.2. Retail Pharmacies & Stores

7.4.3. Online Pharmacies

7.5.    Market Analysis – By Country/ sub-region

7.5.1. U.K.

7.5.2. Germany

7.5.3. France

7.5.4. Spain

7.5.5. Italy

7.5.6. Scandinavia

7.5.7. Rest of Europe

  1. Asia Pacific Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

8.1.    Key Findings / Summary

8.2.    Market Analysis – By Drug Class

8.2.1. Buprenorphine

8.2.2. Methadone

8.2.3. Naltrexone

8.3.    Market Analysis – By Route of Administration

8.3.1. Oral

8.3.2. Parenteral

8.4.    Market Analysis – By Distribution Channel

8.4.1. Hospitals Pharmacies

8.4.2. Retail Pharmacies & Stores

8.4.3. Online Pharmacies

8.5.    Market Analysis – By Country

8.5.1. Japan

8.5.2. China

8.5.3. India

8.5.4. Australia

8.5.5. Southeast Asia

8.5.6. Rest of Asia Pacific

  1. Rest of the World Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026

9.1.    Key Findings / Summary

9.2.    Market Analysis – By Drug Class

9.2.1. Buprenorphine

9.2.2. Methadone

9.2.3. Naltrexone

9.3.    Market Analysis – By Route of Administration

9.3.1. Oral

9.3.2. Parenteral

9.4.    Market Analysis – By Distribution Channel

9.4.1. Hospitals Pharmacies

9.4.2. Retail Pharmacies & Stores

9.4.3. Online Pharmacies

  1. Competitive Analysis

10.1.Key Industry Developments

10.2.Global Market Share Analysis (2017)

10.3.Competition Dashboard

10.4.Comparative Analysis – Major Players

10.5.Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))

10.5.1.    Indivior PLC

10.5.2.    Alkermes

10.5.3.    Orexo US, Inc.

10.5.4.    Titan Pharmaceuticals Inc.

10.5.5.    TEVA PHARMACEUTICALS USA, INC

10.5.6.    Mallinckrodt

10.5.7.    BioDelivery Sciences International Inc.

10.5.8.    Mylan

10.5.9.    Pfizer Inc.

10.5.10.    Hikma Pharmaceuticals

10.5.11.    Camurus

10.5.12.    Other Prominent Players

Continued…

Report Focus:

 

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Opioid Use Disorder (OUD) Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates 
Showing 0 results
Your Answer

Please first to submit.

Get involved

Register

As a member of this site you will be able to receive aggregates news relating only to those categories that are most relevant to you, submit job listings for FREE, post questions in the Q&A, and more.

Register Now

Feature your company

The Feature Your Company listing is your custom-made (by us) profile page that allows you to add any of the following content: text, videos, links, images. The page will also be listed on the Featured Company landing page. Over 560 unique aggregates users visit the site per day! Complete the enquiry form now to contact us.

Contact us

Jobs

Are you looking for an aggregate related job? Click here to see our jobs listing supplied by industry experts United Employment.

See Jobs

Advertise

Reach thousands of budget holders and decision makers by promoting your company on the longest established aggregate website in the US & Canada. Or advertise in our emails which are sent to opted-in subscribers according to their chosen categories. All advertising will display correctly on tablets and mobiles as this site is responsive.